Immunohistochemical biomarkers for bladder cancer prognosis
نویسندگان
چکیده
منابع مشابه
MicroRNAs as biomarkers associated with bladder cancer
Bladder cancer is the fifth most common cancer with significant morbidity and mortality. Recently, numerous studies demonstrated that microRNAs are emerging as diagnostic biomarkers for bladder cancer. Specific miRNA profiles have been identified for several samples from patients with bladder cancer. MicroRNAs are noncoding RNA molecules of approximately 23 nucleotides that play important roles...
متن کاملA review of biomarkers in the diagnosis of bladder cancer
Bladder cancer is among the ten most common cancers and the ten main causes of cancer-related deaths in the world. Currently, bladder tumors are diagnosed and followed up using a combination of cystoscopy and cytology. In addition, bladder cancer often recurs and can progress if not closely monitored after initial treatment. Constant monitoring of the patient with cystoscopy, which is an invasi...
متن کاملmicrornas as biomarkers associated with bladder cancer
bladder cancer is the fifth most common cancer with significant morbidity and mortality. recently, numerous studies demonstrated that micrornas are emerging as diagnostic biomarkers for bladder cancer. specific mirna profiles have been identified for several samples from patients with bladder cancer. micrornas are noncoding rna molecules of approximately 23 nucleotides that play important roles...
متن کاملBiomarkers for bladder cancer: The search continues!
Cystoscopy has remained the gold standard for the detection of bladder cancer for decades. Although many new fancy molecular markers have been developed and are widely applied in the diagnosis and management of various cancers today, no single marker has dethroned cystoscopy as " the tool " in the detection of bladder cancer. Although advances in technology have provided fluorescence and narrow...
متن کاملBiomarkers for Detection, Treatment Decision and Prognosis of the Urinary Bladder Cancer
Currently, there is no perfect test for the detection of bladder cancer. Even the gold standard cystoscopy is increasingly being demonstrated to miss both Tis and papillary bladder cancer. The oldest urine-based biomarker, cytology, has high specificity but has low sensitivity and significant variability in performance. Stage and grade of transitional cell carcinoma are currently the most usefu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Urology
سال: 2011
ISSN: 0919-8172
DOI: 10.1111/j.1442-2042.2011.02809.x